Montreux Capital Management (UK) [MCM UK] has won the prestigious Investor prize at the 2020 LaingBuisson Awards. The award ceremony, which was delayed due to the COVID 19 pandemic, celebrates the best companies across the healthcare sector and was won by MCM UK amidst strong competition.

The Rehabilitation Award was also won by Christchurch Group which is a part of the Active Care Group. The award recognising the sector leading expertise displayed by the division.

Oliver Harris, CEO, Montreux Capital Management (UK) stated: “We are very pleased to win the Investor Award this year. Our business has been consistently at the front of specialist care investing in the UK and will remain so in the coming years. This award recognises our steadfast commitment to consistently deliver for our investors.”

Further details avilable on the LaingBussion website at:

Find Us

Thameside House
Hurst Road
East Molesey

T: + 44 (0) 1932 860 140

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.